EligibleTrials

Clinical trials recruiting for Refractory Cancer

6
Recruiting trials
19
US states with sites
5
Countries
17%
Accept healthy volunteers

Phase breakdown

Phase 1 4Phase 2 4

Drugs and treatments being studied

InterventionTrials
Pembrolizumab2
ADU-18051
GV20-02511
GV20-0251 and Pembrolizumab [KEYTRUDA®]1
IMA203 Product1
IMA203 product- flat dose1
IMA203CD8 Product1
Leflunomide1
MQ7191
Nivolumab1
Omeprazole 80 mg twice daily1
The combination of MEK inhibitor + hydroxychloroquine( plaquenil) ± bevacizumab1

Where trials are recruiting (top US states)

StateRecruiting trials
New York3
California2
Colorado2
Florida2
Massachusetts2
Michigan2
Ohio2
Texas2
Virginia2
Connecticut1
Illinois1
Indiana1

Top cities

New York, New York 3Boston, Massachusetts 2Detroit, Michigan 2Fairfax, Virginia 2Houston, Texas 2Aurora, Colorado 1Basking Ridge, New Jersey 1Canton, Ohio 1Chicago, Illinois 1Columbus, Ohio 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Refractory Cancer often also study these conditions. Each links to its own recruiting-trial list.

Melanoma 487Solid Tumor, Adult 38Lung cancer 2180Colorectal cancer 1359RAS Mutation 6Ras (Kras or Nras) Gene Mutation 3Prostate cancer 1234pMMR/MSS Adenocarcinoma of the Colon or Rectum 3Pancreatic cancer 870Pancreas Cancer 86

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Refractory Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.